SIBprima October 2024 Unified Patent Court Pharma Update – Imminent infringement of pharma patent – Competence of Milan Central Division over pharma
 |
|
UPC CASE LAW Imminent infringement of a medicinal product under UPC rules: an interesting decisionInteresting guidance on the the assessment of the “imminent infringement” of a pharma patent according to Unified Patent Court law is offered by a recent order of the court’s Düsseldorf Local Division, as briefly explained by our Claudio Germinario. (more) |
 |
 |
UPC INSIGHT A close look at the competence over pharmaceuticals of Milan’s UPC Central DivisionThe areas of competence of the Milan section of the UPC’s Central Division have been established by a specific amendment of UPC law; as far as pharma patents are concerned, Milan’s competences may be broader than they appear at first glance, depending on how the wording of relevant UPC laws and rules of procedure is interpreted. (more) |
EVENTS WITH SIB/1Attending the AIPLA 2024 Annual MeetingOur pertner Elisabetta Papa, Sofia Santoro and Benedetta Soranzo are attending the AIPLA 2024 Annual Meeting taking place at the Gaylord National Resort. (more) |
 |
 |
EVENTS WITH SIB/2
See you at the AIPPI World Congress in Hangzhou, ChinaOur partner Andrea Soldatini and Alberto De Ros are looking forward to taking part in the AIPPI World Congress 2024. (more) |
Download PDF